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Objective: The aim of this study was to analyze the blood serum levels of CTX-II in profes-
sional indoor soccer players, at three different times during one season: at the start of the
pre-season, four months later (a time that marks the middle of the season) and at the end
of  the season.
Methods: Fourteen male soccer players of mean age 19 years were included. Blood samples
of  3 mL were collected from each individual. The samples were analyzed by means of Elisa
tests.
Results: There was a signiﬁcant increase in the serum level of CTX-II in the indoor soccer
players, from the beginning to the end of the season (p < 0.01).
Conclusion: These data suggest that joint degradation had occurred in these soccer players,
by  the end of this period. It is evident that further studies are needed, with methodological
rigor, so as to make an effective contribution toward precise elucidation of the etiology of
this  osteoarthritis and its relationship with the biomarkers, as a tool for early diagnosis.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved.
Análise  dos  níveis  séricos  do  biomarcador  CTX-II  em  atletas  proﬁssionais
de  futebol  de  salão  durante  uma  temporada
alavras-chave:
r  e  s  u  m  o
Objetivo: Analisar os níveis séricos sanguíneos de CTX-II em atletas proﬁssionais de futebol
steoartrite
artilagem articular
iomarcadores farmacológicos
de  salão, em três momentos distintos durante uma temporada: no início da pré-temporada,
quatro meses após (período que marca o meio da temporada) e no ﬁm da temporada.
Métodos: Foram incluídos 14 atletas do gênero masculino e média de idade de 19 anos. Foram
coletados 3 mL de sangue de cada indivíduo. As amostras foram analisadas pelo teste do tipo
Elisa.
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Resultados: Houve aumento signiﬁcativo dos níveis séricos de CTX-II nos atletas de futebol
de  salão, comparando-se o início e o ﬁm de uma temporada (p < 0.01).
Conclusão: Esses dados sugerem a ocorrência de degradac¸ão articular nos atletas, ao término
desse período. Fica evidente a necessidade de futuros estudos, com rigor metodológico, que
possam contribuir efetivamente para a elucidac¸ão precisa da etiologia da OA e sua relac¸ão
com  os biomarcadores como instrumento de diagnóstico precoce.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Todos os direitos reservados.Introduction
Primary osteoarthritis (OA) is a multifactorial disease charac-
terized by irreversible joint degeneration, with formation of
osteophytes and reduction of the joint space. It presents the
following main symptoms: progressive increase in pain, loss of
function, limitations on day-to-day activities and restrictions
on sports practice.1–7
Some theories have correlated continual intense practice
of physical activity with development of primary OA in elite
athletes, caused by joint overloading. Moreover, there has been
speculation regarding how the joint cartilage responds to this
overloading. However, the relationship between joint cartilage
damage and intense physical activity still seems to be a matter
of controversy in the literature.8,9
Some studies have demonstrated that athletes who
practice sports that include rapid acceleration with instant
deceleration or continuous training with a high impact on
joints, or who  compete at elite level for prolonged periods of
time, present greater likelihood of developing OA. However,
the types and intensities of exercises that are harmful to joint
cartilage remain unknown.8–11
OA presents an initial asymptomatic phase, which may
be inﬂuenced by the level of overloading to which the joint
is exposed in a physical activity. However, identiﬁcation
of this joint damage is difﬁcult, given the limitations of
the assessment instruments available. In this light, recent
studies have demonstrated that biochemical biomarkers
are a potential option for early detection of asymptomatic
OA.9,12,13
Under physiological conditions, the metabolism of type II
collagen is slow. Its ﬁbrils have a half-life measured in years.
In the initial stages of cartilage degeneration, degradation of
these collagen ﬁbrils is observed. Enzymes named metallo-
proteinases are released, and these contribute toward this
degradation, especially collagenases and aggrecanases. Col-
lagenases are responsible for cleaving type II collagen and
produce fragments of this collagen. Speciﬁc antibodies for
these fragments can be detected in synovial ﬂuid, blood or
urine and have been studied as potential biomarkers for the
onset of joint degradation.2,5,7
When a joint component is degraded and ejected out of its
original tissue, measuring this in the joint ﬂuid would be the
most precise method. One biomarker of joint degradation is
the C-telopeptide of type II collagen (CTX-II). Use of CTX-II as
a marker for progression of cartilaginous lesions and its direct
relationship with radiological grades and clinical scores for
OA have been proven in the literature. Therefore, assaying ofCTX-II levels seems to be an effective manner for ascertaining
type II collagen turnover.14–21
Biomarkers are instruments for measuring the progression
of diseases or the effects of treatment on disease progres-
sion. Thus, they can serve as tools for elucidating the effects
of exercise on joint cartilage and the possible development
of primary OA.12,13 In this light, the objective of the present
study was to analyze and compare blood serum assay levels
of the biomarker CTX-II in professional indoor soccer players,
at three different times during one season.
Methods
This was a prospective longitudinal study that was approved
by the Research Ethics Committee of Santa Casa de Misericór-
dia de São Paulo.
The study included 14 players in a professional indoor soc-
cer team (under-21 category). The players were male, of mean
age 19 years, all in the same team, and were subjected to the
same training and match load.
Players with previous knee surgery (two players) or who
were using chondroprotectant medications (three players)
were excluded.
In addition, four players who were undergoing physio-
therapy treatment for femoropatellar overload due to muscle
imbalance in the pelvic belt were excluded because they pre-
sented pain of patellar origin that limited their sports practice
at the beginning of the season.
CTX-II levels were assayed at three times: A – at the begin-
ning of the pre-season; B – four months later (a time that
marked the middle of the season); and C – at the end of the
season.
Blood samples (3 mL)  were collected from each individual
by means of simple puncture in the non-dominant arm, using
vacuum collection kits. The blood samples were centrifuged
and stored at a temperature of −80 degrees, until all the sam-
ples were ready to be tested.
Each sample was analyzed by means of an ELISA test for
detecting human CTX-II (Hu CTX-II kit, Cusabio Biotech, cata-
log number CSB – E09323h, batch S20045731, produced in the
United States). This kit presents 100% speciﬁcity for human
CTX-II alone, without cross-reactions, and with a minimum
detectable level of lower than 0.3 ng/mL. This test was per-
formed in a private laboratory in the city of São Paulo, with
costs entirely borne by the researchers.To compare the assayed levels between the three evalu-
ation times, the nonparametric paired Wilcoxon statistical
test and Bonferroni correction for multiple comparisons were
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Table 1 – Data on individuals and their CTX-II assay levels (in ng/mL), observed for each player at each time during the
season.
Age Intensity of pain Beginning of season Middle of season End of season
Player 1 19 No pain 0.321 0.328 0.328
Player 2 18 No pain 0.201 0.278 0.401
Player 3 19 Occasional non-limiting pain 0.182 0.331 0.551
Player 4 20 No pain 0.825 1.121 2.537
Player 5 20  Occasional non-limiting pain 0.312 0.298 0.399
Player 6 19  Occasional non-limiting pain 0.311 0.315 0.324
Player 7 19 Limiting pain 0.299 0.311 0.324
Player 8 20 Occasional non-limiting pain 0.282 0.301 0.309
Player 9 20 No pain 0.311 0.315 0.497
Player 10 20 Occasional non-limiting pain 0.892 2.012 2.349
Player 11 17 No pain 0.312 0.299 0.395
Player 12 19 No pain 0.287 0.277 0.268
Player 13 17 Occasional non-limiting pain 0.347 0.521 0.577
Player 14 19 No pain 0.247 0.317 0.378
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ning and the end of the season, there was a signiﬁcant increase
in the level of the CTX-II joint degradation biomarker, irre-
spective of whether the extreme results were taken into
consideration.
Table 2 – Comparison of assayed levels for the
biomarker CTX-II (in ng/mL) observed between the
different times during the season. Complete data (14
players) and reduced data (12 players: players 4 and 10
were  disregarded).
Comparison Mean difference p
Complete data
Beginning vs. middle 0.134 0.06
Middle vs. end 0.186 0.02
Beginning vs. end 0.320 0.003
Reduced dataMean (SD) 19 
pplied (95% conﬁdence interval and p value <0.05). This non-
arametric test was the best option because it was impossible
o assume that the sample had normal distribution.
esults
able 1 presents the data on each individual and the marker
evels observed for each of them at each time during the sea-
on. It could be seen that two players (4 and 10) presented
iscrepant data, with much higher assayed levels than those of
he other players evaluated in this study, in all the evaluations.
evertheless, these participants did not report any decline in
hysical performance, or any presence of symptoms such as
ain, edema or instability.
Individuals 3, 5 and 10 presented pain at the origin of
he patellar tendon in one knee, which became worse at
he end of the sports practice, improved with physiother-
py and did not limit their participation in training and
atches. Individual 13 presented a condition of non-limiting
ain above the insertion of the pes anserinus. Also, individ-
als 6 and 8 complained of lateral pain in their knees, above
he lateral epicondyle, during sports practice, which was also
on-limiting.
Because of the tendinous origin of the pain in the individ-
als included in this study (patellar tendinopathy, anserine
endinopathy and friction of the iliotibial tract), it was decided
ot to include them separately in statistical comparisons
egarding degradation of type II collagen exclusively of the
artilaginous tissue.
omparison  of  CTX-II  assay  levels  between  different  times
uring  the  season
ecause of the limited size of the sample, which was selected
n a non-randomized manner because this was a closed
ndoor soccer team, the distribution of the individuals and
esults from the sample cannot be considered to be normal.
hen this occurs, nonparametric statistical tests need to be
sed. In the graphic distribution of the data, two individu-
ls had values that were very different from those of the0.366 ± 0.214 0.5 ± 0.485 0.685 ± 0.751
remainder of the team and which were considered to be out-
liers.
To avoid the risk of statistical error, two separate analyses
were performed: 1 – comparisons using the complete data; and
2 – comparisons using reduced data (without the information
on players 4 and 10) (Table 2).
In comparing the values from the ﬁrst two analyses, i.e.
beginning of the season versus middle of the season, no sta-
tistically signiﬁcant differences between the samples could be
seen, in either of the comparisons (1 and 2).
In the analysis between the middle and the end of the
season, there was a signiﬁcant difference in assayed levels,
in the comparison among the 14 participants (p < 0.02). How-
ever, when players 4 and 10 were taken out of the analysis,
no signiﬁcant difference could be seen (analysis with reduced
data).
In comparing the beginning and end of the season, both
analyses (comparisons 1 and 2) indicated that there was a sta-
tistically signiﬁcant increase in the CTX-II biomarker (p < 0.003
and p < 0.01, respectively). In other words, between the begin-Beginning vs. middle 0.041 0.19
Middle vs. end 0.069 0.06
Beginning vs. end 0.109 0.01
p . 2 0 
r
1
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Discussion
This study aimed to analyze and compare blood serum assay
levels for the biomarker CTX-II among professional indoor soc-
cer players, at three different times during one season. From
the results observed, it could be seen that there was a statis-
tically signiﬁcant increase in CTX-II between the beginning
and end of the season. It has been well established in the
literature that increased levels of the biomarker CTX-II are a
predictive factor for joint degradation. Thus, it is believed that
early identiﬁcation of CTX-II levels would be a useful tool for
making equally early diagnoses of primary osteoarthritis (OA)
and taking preventive action.22,23
Corroborating the ﬁndings of the present study, O’Kane
et al.22 evaluated different sports categories and demonstrated
through urine analyses that samples from marathon run-
ners presented higher CTX-II levels than those of swimmers
or rowers. According to these authors, runners expose their
lower-limb joints to repetitive axial overloading, which may
cause early damage to their joint cartilage.
The pure and simple increase in CTX-II in the players
studied here does not necessarily mean that they are suf-
fering or will suffer osteoarthrosis. It is known that patients
with arthrosis have high levels of this serum biomarker and
increased levels are directly related to radiographic worsening,
according to the Kelgreen-Laurence classiﬁcation.16 What we
can be sure of from these data is that, at least during competi-
tions, chondral degradation was higher in the patients studied,
since the biomarker CTX-II comes from destruction of type II
collagen, exclusively in joint cartilage.
It is possible that changes to training, intensiﬁcation of
anaerobic exercises with muscle strengthening, compulsory
physiotherapeutic follow-up and even use of chondroprotec-
tant medications might be viable solutions for joint protection.
In order to protect the joint health of soccer players, teams
should start to think about this type of preventive strategy.
After all, the aim today should be prevention before
treatment. Injury avoidance through practicing preventive
medicine should be the focus of exercise and sports medicine,
since careers can certainly be prolonged in this manner.
The possible limitations of this study are the small sample
size (n = 14) and the absence of a control group for comparisons
between ﬁndings. The sample size is explained by the fact
that this study investigated a single team within this category,
whose members were all subjected to the same training and
competition loads. It was decided not to use a control group,
because our aim was only to ascertain whether there would
be any increase in joint collagen degradation over the course
of a single season of training and competition. In other words,
the individuals became their own controls.
Other studies underway within the Sports Trauma Group
of Santa Casa de São Paulo are comparing types of sports and
control groups, including indoor soccer. Preliminary studies
indicate that there are large differences regarding type II col-
lagen degradation.
The discrepancies encountered in our sample, in two of
the individuals analyzed, can be explained by a variety of
theories. These include the notions that the markers may
have been inﬂuenced by the individuals’ hormonal state, diet
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or genetic factors,22 given that neither of these individuals
reported any reduction in physical performance, or any symp-
toms such as pain, edema or instability. According to Dam
et al.,24 the amount of cartilage degradation estimated from
the biomarker CTX-II is related to the presence of pain.
Conclusion
There was a signiﬁcant increase in the serum levels of CTX-
II in the indoor soccer players, comparing the beginning and
end of the season. These data suggest that increased degra-
dation of type II joint collagen was occurring at the end of
this period. It is clear that further studies are needed, with
appropriate methodological rigor, so as to make effective con-
tributions toward precise elucidation of the etiology of OA and
its relationship with biomarkers as a tool for early diagnosis.
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